Sotalol Hydrochloride Tablet
Product Images NDC 51655-450

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 51655-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-450-15 (51655 450 15 Rev A 06 23)

51655-450-15 (51655 450 15   Rev A 06 23)
Sotalol Hydrochloride Tablets, USP 240 mg oral tablets packaging label. The label states a quantity of 50 tablets and is marked Rx Only. Storage instructions are provided, including temperature ranges and warnings to keep out of reach of children and to store in the original container. The label includes barcode, repackager information (Northwind Pharmaceuticals, Indianapolis, IN), and batch identifiers.*
FDA Label Image

Figure.jpg (Figure)

Figure.jpg (Figure)
A line chart depicting the Age Factor versus Age in months for Sotalol Hydrochloride. The Age Factor increases progressively with age, starting near 0.2 at 0.1 months and approaching 1.0 at about 24 months, indicating stabilization beyond this age.*
FDA Label Image

Figure2study1.jpg (Figure2study1)

Figure2study1.jpg (Figure2study1)
A Kaplan-Meier survival curve chart showing recurrence-free survival over time (days) comparing oral Sotalol at doses of 80 mg, 120 mg, and 160 mg versus placebo. The chart includes p-values for log-rank tests between Sotalol and placebo at each dose level.*
FDA Label Image

Figure3study2.jpg (Figure3study2)

Figure3study2.jpg (Figure3study2)
A Kaplan-Meier survival curve chart comparing recurrence-free survival over time (days) between oral Sotalol Hydrochloride and placebo groups. The vertical axis represents recurrence-free survival proportion, and the horizontal axis shows time in days up to 180 days. The chart includes a p-value from a log-rank test comparing oral Sotalol with placebo.*
FDA Label Image

Structur.jpg (Structurefigure)

Structur.jpg (Structurefigure)
Chemical structure of Sotalol Hydrochloride shown with its molecular components and bonds depicting the arrangement of atoms including a sulfonamide group, aromatic ring, and hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.